End-of-Life and Palliative Care Issues for Patients Living with Pulmonary Arterial Hypertension: Barriers and Opportunities

 

 Buy Article Permissions and Reprints

Abstract

Pulmonary arterial hypertension (PAH) is a progressive, incurable disease that results in significant symptom burden, health care utilization, and eventually premature death. Despite the advancements made in treatment and management strategies, survival has remained poor. End-of-life care is a challenging issue in management of PAH, especially when patients are in younger age group. End-of-life care revolves around symptom palliation and reducing psychosocial disease burden for a dying patient and entails advanced care planning that are often challenging. Thus, support from palliative care specialist becomes extremely important in these patients. Early introduction to palliative care in patients with high symptom burden and psychosocial suffering is suggested. Despite of the benefits of an early intervention, palliative care remains underutilized in patients with PAH, and this significantly raises issues around end-of-life care in PAH. In this review, we will discuss the opportunities offered and the existing barriers in addressing high symptom burden and end-of-life care issues. We will focus on the current evidence, identify areas for future research, and provide a call-to-action for better guidance to PAH specialists in making timely, appropriate interventions that can help mitigate end-of-life care issues.

Publication History

Article published online:
17 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Benza RL, Gomberg-Maitland M, Elliott CG. et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL Risk Score Calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest 2019; 156 (02) 323-337
  CrossrefPubMedGoogle Scholar
• 2 Humbert M, Kovacs G, Hoeper MM. et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43 (38) 3618-3731
  CrossrefPubMedGoogle Scholar
• 3 Halimi L, Suehs CM, Marin G. et al. Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study. ERJ Open Res 2021; 7 (03) 00617-2020
  CrossrefPubMedGoogle Scholar
• 4 Olsson KM, Meltendorf T, Fuge J. et al. Prevalence of mental disorders and impact on quality of life in patients with pulmonary arterial hypertension. Front Psychiatry 2021; 12 (May): 667602
  CrossrefPubMedGoogle Scholar
• 5 Rawlings GH, Thompson AR, Armstrong I, Novakova B, Beail N. Coping styles associated with depression, health anxiety and health-related quality of life in pulmonary hypertension: cross-sectional analysis. BMJ Open 2022; 12 (08) e062564
  CrossrefPubMedGoogle Scholar
• 6 Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35 (05) 1079-1087
  CrossrefPubMedGoogle Scholar
• 7 Chang KY, Duval S, Badesch DB. et al; PHAR Investigators*. Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry. J Am Heart Assoc 2022; 11 (09) e024969
  CrossrefPubMedGoogle Scholar
• 8 Chiang YC, Hu LY, Couper J. et al. Exploring the experiences and psychosocial stresses of Taiwanese patients with pulmonary hypertension: a qualitative interview study. Pulm Circ 2018; 8 (03) 2045894018787479
  CrossrefPubMedGoogle Scholar
• 9 Caldarone F, Gebhardt P, Hoeper MM. et al. Metacognitions in patients with frequent mental disorders after diagnosis of pulmonary arterial hypertension. Front Psychiatry 2022; 13 (April): 812812
  CrossrefPubMedGoogle Scholar
• 10 Christiansen D, Porter S, Hurlburt L, Weiss A, Granton J, Wentlandt K. Pulmonary arterial hypertension: a palliative medicine review of the disease, its therapies, and drug interactions. J Pain Symptom Manage 2020; 59 (04) 932-943
  CrossrefPubMedGoogle Scholar
• 11 Anand V, Vallabhajosyula S, Cheungpasitporn W. et al. Inpatient palliative care use in patients with pulmonary arterial hypertension: temporal trends, predictors, and outcomes. Chest 2020; 158 (06) 2568-2578
  CrossrefPubMedGoogle Scholar
• 12 Ferrell BR, Twaddle ML, Melnick A, Meier DE. National consensus project clinical practice guidelines for quality palliative care guidelines. J Palliat Med 2018; 21 (12) 1684-1689
  CrossrefPubMedGoogle Scholar
• 13 Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ 2005; 330 (7498): 1007-1011
  CrossrefPubMedGoogle Scholar
• 14 Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA 2003; 289 (18) 2387-2392
  CrossrefPubMedGoogle Scholar
• 15 Galiè N, Humbert M, Vachiery JL. et al; ESC Scientific Document Group. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37 (01) 67-119
  CrossrefPubMedGoogle Scholar
• 16 Fenstad ER, Shanafelt TD, Sloan JA. et al. Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey. Pulm Circ 2014; 4 (03) 504-510
  CrossrefPubMedGoogle Scholar
• 17 Sahay S, Balasubramanian V, Memon H. et al. Utilization of risk assessment tools in management of PAH: a PAH provider survey. Pulm Circ 2022; 12 (02) e12057
  CrossrefPubMedGoogle Scholar
• 18 Rohlfing AB, Bischoff KE, Kolaitis NA. et al. Palliative care referrals in patients with pulmonary arterial hypertension: the Pulmonary Hypertension Association Registry. Respir Med 2023; 206: 107066
  CrossrefPubMedGoogle Scholar
• 19 Wilson M, Anguiano RH, Awdish RLA. et al. An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension. Pulm Circ 2022; 12 (01) e12003
  CrossrefPubMedGoogle Scholar
• 20 Vallabhajosyula S, Prasad A, Dunlay SM. et al. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15-year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc 2019; 8 (15) e011954
  CrossrefPubMedGoogle Scholar
• 21 Alqahtani F, Balla S, Almustafa A, Sokos G, Alkhouli M. Utilization of palliative care in patients hospitalized with heart failure: a contemporary national perspective. Clin Cardiol 2019; 42 (01) 136-142
  CrossrefPubMedGoogle Scholar
• 22 Rush B, Hertz P, Bond A, McDermid RC, Celi LA. Use of palliative care in patients with end-stage COPD and receiving home oxygen: national trends and barriers to care in the United States. Chest 2017; 151 (01) 41-46
  CrossrefPubMedGoogle Scholar
• 23 Mulvey CL, Smith TJ, Gourin CG. Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer. Head Neck 2016; 38 (03) 355-363
  CrossrefPubMedGoogle Scholar
• 24 Loh KP, Abdallah M, Shieh MS. et al. Use of inpatient palliative care services in patients with advanced cancer receiving critical care therapies. J Natl Compr Canc Netw 2018; 16 (09) 1055-1064
  CrossrefPubMedGoogle Scholar
• 25 Schoenherr LA, Bischoff KE, Marks AK, O'Riordan DL, Pantilat SZ. Trends in hospital-based specialty palliative care in the United States from 2013 to 2017. JAMA Netw Open 2019; 2 (12) e1917043
  CrossrefPubMedGoogle Scholar
• 26 Hoeper MM, Galié N, Murali S. et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165 (03) 341-344
  CrossrefPubMedGoogle Scholar
• 27 Yang JZ, Odish MF, Mathers H. et al. Outcomes of cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Pulm Circ 2022; 12 (02) e12066
  CrossrefPubMedGoogle Scholar
• 28 Tonelli AR, Arelli V, Minai OA. et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med 2013; 188 (03) 365-369
  CrossrefPubMedGoogle Scholar
• 29 Cardenas V, Rahman A, Zhu Y, Enguidanos S. Reluctance to accept palliative care and recommendations for improvement: findings from semi-structured interviews with patients and caregivers. Am J Hosp Palliat Care 2022; 39 (02) 189-195
  CrossrefPubMedGoogle Scholar
• 30 Brown CE, Steiner JM, Leary PJ, Curtis JR, Engelberg RA. A world of maximalist medicine: physician perspectives on palliative care and end-of-life for patients with pulmonary arterial hypertension. J Pain Symptom Manage 2023; 65 (04) e329-e335
  CrossrefPubMedGoogle Scholar
• 31 Grinnan DC, Swetz KM, Pinson J, Fairman P, Lyckholm LJ, Smith T. The end-of-life experience for a cohort of patients with pulmonary arterial hypertension. J Palliat Med 2012; 15 (10) 1065-1070
  CrossrefPubMedGoogle Scholar
• 32 Swetz KM, Shanafelt TD, Drozdowicz LB. et al. Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. J Heart Lung Transplant 2012; 31 (10) 1102-1108
  CrossrefPubMedGoogle Scholar
• 33 Hrustanovic-Kadic M, Ziegler C, El-Kersh K. Palliative care perception in pulmonary arterial hypertension: evaluating the interaction of PPCI, PAH-SYMPACT questionnaire, and the reveal 2.0 risk score. Ann Am Thorac Soc 2021; 18 (02) 361-364
  CrossrefPubMedGoogle Scholar
• 34 Nelson KE, Wright R, Peeler A, Brockie T, Davidson PM. Sociodemographic disparities in access to hospice and palliative care: an integrative review. Am J Hosp Palliat Care 2021; 38 (11) 1378-1390
  CrossrefPubMedGoogle Scholar
• 35 Johnson KS. Racial and ethnic disparities in palliative care. J Palliat Med 2013; 16 (11) 1329-1334
  CrossrefPubMedGoogle Scholar
• 36 Ivey GD, Johnston FM. Barriers to equitable palliative care utilization among patients with cancer. Surg Oncol Clin N Am 2022; 31 (01) 9-20
  CrossrefPubMedGoogle Scholar
• 37 Enguidanos S, Lomeli S, Kogan AC, Rahman A, Lewis N. Home-based palliative care team perspectives on challenges in patient referral and enrollment. J Pain Symptom Manage 2022; 63 (05) 665-672
  CrossrefPubMedGoogle Scholar
• 38 Khirfan G, Tonelli AR, Ramsey J, Sahay S. Palliative care in pulmonary arterial hypertension: an underutilised treatment. Eur Respir Rev 2018; 27 (150) 180069
  CrossrefPubMedGoogle Scholar
• 39 Gu S, Hu H, Dong H. Systematic review of health-related quality of life in patients with pulmonary arterial hypertension. PharmacoEconomics 2016; 34 (08) 751-770
  CrossrefPubMedGoogle Scholar
• 40 Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev 2015; 24 (138) 621-629
  CrossrefPubMedGoogle Scholar
• 41 Chiu JS, Zuckerman WA, Turner ME. et al. Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes. J Heart Lung Transplant 2015; 34 (03) 376-380
  CrossrefPubMedGoogle Scholar
• 42 Sandoval J, Gaspar J, Peña H. et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J 2011; 38 (06) 1343-1348
  CrossrefPubMedGoogle Scholar
• 43 Rajeshkumar R, Pavithran S, Sivakumar K, Vettukattil JJ. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv 2017; 90 (07) 1145-1153
  CrossrefPubMedGoogle Scholar
• 44 Chen SL, Zhang FF, Xu J. et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol 2013; 62 (12) 1092-1100
  CrossrefPubMedGoogle Scholar
• 45 Zhang H, Wei Y, Zhang C. et al. Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized PADN-CFDA trial. JACC Cardiovasc Interv 2022; 15 (23) 2412-2423
  CrossrefPubMedGoogle Scholar
• 46 Bobhate P, Mohanty SR, Tailor K. et al. Potts shunt as an effective palliation for patients with end stage pulmonary arterial hypertension. Indian Heart J 2021; 73 (02) 196-204
  CrossrefPubMedGoogle Scholar
• 47 Kim SH, Jang WS, Lim HG, Kim YJ. Potts shunt in patients with primary pulmonary hypertension. Korean J Thorac Cardiovasc Surg 2015; 48 (01) 52-54
  CrossrefPubMedGoogle Scholar
• 48 Said SM. Commentary: Right ventricular unloading with valved conduit for end-stage pulmonary arterial hypertension: when Eisenmenger is the last hurrah. J Thorac Cardiovasc Surg 2021; 161 (04) 1447-1448
  CrossrefPubMedGoogle Scholar
• 49 Goldar G, Chaisson N, Ghobrial J. Transcatheter valve implantation in reversed Potts shunt in pulmonary arterial hypertension: keeping the shunt reversed. JACC Case Rep 2022; 4 (24) 101678
  CrossrefPubMedGoogle Scholar
• 50 Vanhoof M J, Delcroix M, Vandevelde E. et al. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J Heart Lung Transplant 2014; 33 (08) 800-808
  CrossrefPubMedGoogle Scholar
• 51 Pfeuffer E, Krannich H, Halank M. et al. Anxiety, depression, and health-related QOL in patients diagnosed with PAH or CTEPH. Lung 2017; 195 (06) 759-768
  CrossrefPubMedGoogle Scholar
• 52 Zhang J, Yin Y, Wen Y, Shi F, Wang J. Anxiety and depression in patients with pulmonary arterial hypertension in Northwest China: a cross-sectional study. Front Psychiatry 2022; 12 (February): 758120
  CrossrefPubMedGoogle Scholar
• 53 Mai AS, Lim OZH, Ho YJ. et al. Prevalence, risk factors and intervention for depression and anxiety in pulmonary hypertension: a systematic review and meta-analysis. Front Med (Lausanne) 2022; 9 (February): 765461
  CrossrefPubMedGoogle Scholar
• 54 Rawlings GH, Beail N, Armstrong I, Thompson AR. Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial. ERJ Open Res 2022; 8 (01) 00526-2021
  CrossrefPubMedGoogle Scholar
• 55 Chen SL, Zhang H, Xie DJ. et al. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study. Circ Cardiovasc Interv 2015; 8 (11) e002837
  CrossrefPubMedGoogle Scholar
• 56 Rosenzweig EB, Ankola A, Krishnan U, Middlesworth W, Bacha E, Bacchetta M. A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults. J Thorac Cardiovasc Surg 2021; 161 (04) 1438-1446.e2
  CrossrefPubMedGoogle Scholar